Related Experiment Video
Updated: Jun 12, 2026

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
Published on: September 7, 2022
Primary infection with the Epstein-Barr virus and risk of multiple sclerosis
Lynn I Levin1, Kassandra L Munger, Eilis J O'Reilly
1Department of Epidemiology, Division of Preventive Medicine, Walter Reed Army Institute of Research, Silver Spring, MD, USA.
Abstract:
To determine whether multiple sclerosis (MS) risk increases following primary infection with the Epstein-Barr virus (EBV), we conducted a nested case-control study including 305 individuals who developed MS and 610 matched controls selected among the >8 million active-duty military personnel whose serum has been stored in the Department of Defense Serum Repository. Time of EBV infection was determined by measuring antibody titers in serial serum samples collected before MS onset among cases, and on matched dates among controls. Ten (3.3%) cases and 32 (5.2%) controls were initially EBV negative. All of the 10 EBV-negative cases became EBV positive before MS onset; in contrast, only 35.7% (n = 10) of the 28 controls with follow-up samples seroconverted (exact p value = 0.0008). We conclude that MS risk is extremely low among individuals not infected with EBV, but it increases sharply in the same individuals following EBV infection.
Insights
Multiple sclerosis (MS) risk is very low without Epstein-Barr virus (EBV) infection. However, the risk of developing MS sharply increases after primary EBV infection in individuals.
Area of Science:
- Neurology
- Infectious Diseases
- Epidemiology
Background:
- Multiple sclerosis (MS) is a chronic neurological disease with increasing incidence.
- The role of Epstein-Barr virus (EBV) in MS pathogenesis remains a significant area of research.
- Understanding the temporal relationship between EBV infection and MS onset is crucial for prevention and treatment strategies.
Purpose of the Study:
- To investigate the association between primary Epstein-Barr virus (EBV) infection and the subsequent risk of developing multiple sclerosis (MS).
- To determine if EBV seroconversion precedes the onset of MS.
Main Methods:
- A nested case-control study design was employed.
- Serum samples from over 8 million active-duty military personnel were analyzed.
- Cases (n=305) who developed MS were matched with controls (n=610) based on demographic and military service data.
- Serial serum samples were tested for EBV antibody titers to determine the timing of primary infection.
Main Results:
- A small proportion of individuals in both case and control groups were initially EBV-negative.
- All EBV-negative cases seroconverted to EBV-positive prior to MS onset.
- In contrast, a significantly lower proportion of EBV-negative controls seroconverted during the follow-up period (p=0.0008).
Conclusions:
- The risk of developing MS is minimal in individuals uninfected with EBV.
- Primary EBV infection is strongly associated with a sharp increase in MS risk.
- These findings highlight EBV as a critical factor in the development of multiple sclerosis.
Related Concept Videos
Multiple Sclerosis l: Introduction
Encephalitis ll: Pathophysiology
Viral Meningitis
Encephalitis l: Introduction
Cytomegalovirus Disease
Poliomyelitis

